File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.tripleo.2005.09.018
- Scopus: eid_2-s2.0-33748751963
- PMID: 16997111
- WOS: WOS:000241115200007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Short-term therapeutic outcome of intra-articular high molecular weight hyaluronic acid injection for nonreducing disc displacement of the temporomandibular joint
Title | Short-term therapeutic outcome of intra-articular high molecular weight hyaluronic acid injection for nonreducing disc displacement of the temporomandibular joint |
---|---|
Authors | |
Issue Date | 2006 |
Publisher | Mosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/tripleo |
Citation | Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology And Endodontology, 2006, v. 102 n. 4, p. 453-461 How to Cite? |
Abstract | In a patient with temporomandibular disorder who does not respond to conservative treatment, treatment with intra-articular injection of high molecular weight sodium hyaluronate can be suggested. In our study, 27 patients with nonreduced disc displacement were diagnosed clinically and confirmed by magnetic resonance imaging. The age range was from 21 to 63 years old, with a mean of 39.3 years. Two cycles of injection of high molecular weight sodium hyaluronate was performed on alternative weeks. Pain intensity was measured by the visual analog scale. Maximal mouth opening, clicking joint noise, and lateral movement were measured before and after injection for more than 6 months. Reduction of pain intensity and improvement in the maximum mouth opening parameter was statistically significant. In conclusion, this intra-articular injection using high molecular weight sodium hyaluronate looks very positive for patients affected by nonreduced disc displacement and is encouraged to be used as a primary treatment of temporomandibular joint dysfunction. © 2006 Mosby, Inc. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/154425 |
ISSN | 2011 Impact Factor: 1.457 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yeung, RWK | en_US |
dc.contributor.author | Chow, RLK | en_US |
dc.contributor.author | Samman, N | en_US |
dc.contributor.author | Chiu, K | en_US |
dc.date.accessioned | 2012-08-08T08:25:15Z | - |
dc.date.available | 2012-08-08T08:25:15Z | - |
dc.date.issued | 2006 | en_US |
dc.identifier.citation | Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology And Endodontology, 2006, v. 102 n. 4, p. 453-461 | en_US |
dc.identifier.issn | 1079-2104 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/154425 | - |
dc.description.abstract | In a patient with temporomandibular disorder who does not respond to conservative treatment, treatment with intra-articular injection of high molecular weight sodium hyaluronate can be suggested. In our study, 27 patients with nonreduced disc displacement were diagnosed clinically and confirmed by magnetic resonance imaging. The age range was from 21 to 63 years old, with a mean of 39.3 years. Two cycles of injection of high molecular weight sodium hyaluronate was performed on alternative weeks. Pain intensity was measured by the visual analog scale. Maximal mouth opening, clicking joint noise, and lateral movement were measured before and after injection for more than 6 months. Reduction of pain intensity and improvement in the maximum mouth opening parameter was statistically significant. In conclusion, this intra-articular injection using high molecular weight sodium hyaluronate looks very positive for patients affected by nonreduced disc displacement and is encouraged to be used as a primary treatment of temporomandibular joint dysfunction. © 2006 Mosby, Inc. All rights reserved. | en_US |
dc.language | eng | en_US |
dc.publisher | Mosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/tripleo | en_US |
dc.relation.ispartof | Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Dislocations - Drug Therapy | en_US |
dc.subject.mesh | Facial Pain - Drug Therapy | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-Up Studies | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hyaluronic Acid - Administration & Dosage | en_US |
dc.subject.mesh | Injections, Intra-Articular | en_US |
dc.subject.mesh | Magnetic Resonance Imaging | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Molecular Weight | en_US |
dc.subject.mesh | Range Of Motion, Articular | en_US |
dc.subject.mesh | Temporomandibular Joint Disorders - Drug Therapy | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.title | Short-term therapeutic outcome of intra-articular high molecular weight hyaluronic acid injection for nonreducing disc displacement of the temporomandibular joint | en_US |
dc.type | Article | en_US |
dc.identifier.email | Samman, N:nsamman@hkucc.hku.hk | en_US |
dc.identifier.authority | Samman, N=rp00021 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.tripleo.2005.09.018 | en_US |
dc.identifier.pmid | 16997111 | - |
dc.identifier.scopus | eid_2-s2.0-33748751963 | en_US |
dc.identifier.hkuros | 127666 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-33748751963&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 102 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.spage | 453 | en_US |
dc.identifier.epage | 461 | en_US |
dc.identifier.isi | WOS:000241115200007 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Yeung, RWK=7102833345 | en_US |
dc.identifier.scopusauthorid | Chow, RLK=14621379900 | en_US |
dc.identifier.scopusauthorid | Samman, N=7006413627 | en_US |
dc.identifier.scopusauthorid | Chiu, K=36950846800 | en_US |
dc.identifier.issnl | 1079-2104 | - |